Presentation is loading. Please wait.

Presentation is loading. Please wait.

The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy Mouhannad Al-Douahji, James Brugarolas,

Similar presentations


Presentation on theme: "The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy Mouhannad Al-Douahji, James Brugarolas,"— Presentation transcript:

1 The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy Mouhannad Al-Douahji, James Brugarolas, Paul A.J. Brown, Catherine O. Stehman-Breen, Charles E. Alpers, Stuart J. Shankland Kidney International Volume 56, Issue 5, Pages 1691-1699 (November 1999) DOI: 10.1046/j.1523-1755.1999.00728.x Copyright © 1999 International Society of Nephrology Terms and Conditions Terms and Conditions

2 Figure 1 Kidney International 1999 56, 1691-1699DOI: (10.1046/j.1523-1755.1999.00728.x) Copyright © 1999 International Society of Nephrology Terms and Conditions Terms and Conditions

3 Figure 2 Kidney International 1999 56, 1691-1699DOI: (10.1046/j.1523-1755.1999.00728.x) Copyright © 1999 International Society of Nephrology Terms and Conditions Terms and Conditions

4 Figure 3 Kidney International 1999 56, 1691-1699DOI: (10.1046/j.1523-1755.1999.00728.x) Copyright © 1999 International Society of Nephrology Terms and Conditions Terms and Conditions


Download ppt "The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy Mouhannad Al-Douahji, James Brugarolas,"

Similar presentations


Ads by Google